![Mattias Münnich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mattias Münnich
Direktor/Vorstandsmitglied bei
Magamu AB
Profil
Mattias Münnich founded Stayble Therapeutics AB in 2015, where he worked as Chief Operating Officer from 2022 to 2023.
Mr. Münnich also founded PharmaSurgics In Sweden AB, where he worked as Manager-Business Development.
Mr. Münnich also currently works at Magamu AB, as Director from 2011, Alpha Theraphy Solutions AB, as Director from 2019, Atley Solutions AB, as Director, and Chalmers Ventures AB, as Seed Investment Manager from 2024.
Mr. Münnich also formerly worked at AcuCort AB, as Chief Executive Officer, Mevia AB, as Director, and Ziccum AB, as Independent Director from 2018 to 2022.
Mr. Münnich received his undergraduate degree and graduate degree from Chalmers School of Entrepreneurship.
Aktive Positionen von Mattias Münnich
| Unternehmen | Position | Beginn |
|---|---|---|
Magamu AB
 Magamu AB Miscellaneous Commercial ServicesCommercial Services Engages in trading of goods | Direktor/Vorstandsmitglied | 01.01.2011 |
Alpha Theraphy Solutions AB | Direktor/Vorstandsmitglied | 01.01.2019 |
Atley Solutions AB
 Atley Solutions AB Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Direktor/Vorstandsmitglied | - |
Chalmers Ventures AB
 Chalmers Ventures AB Investment ManagersFinance Chalmers Ventures invests in companies located in Sweden. The firm targets companies operating in the field of technology sector. It provides financing for pre-seed, seed & growth stage capital requirements with an investment size of up to SEK 1 million in pre-seed stage, up to SEK 5 million in seed stage and up to SEK 20 million in growth stage transactions. It also act as co-investor. | Private Equity Investor | 01.02.2024 |
Ehemalige bekannte Positionen von Mattias Münnich
| Unternehmen | Position | Ende |
|---|---|---|
| STAYBLE THERAPEUTICS AB | Gründer | 01.12.2023 |
| ZICCUM AB | Direktor/Vorstandsmitglied | 01.05.2022 |
| ACUCORT AB | Vorstandsvorsitzender | - |
Mevia AB
 Mevia AB Other Consumer ServicesConsumer Services Provides drug package that helps patients manage their drug intake | Direktor/Vorstandsmitglied | - |
PharmaSurgics In Sweden AB
 PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Gründer | - |
Ausbildung von Mattias Münnich
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
PharmaSurgics In Sweden AB
PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Chalmers School of Entrepreneurship
 Chalmers School of Entrepreneurship Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AcuCort AB
 AcuCort AB Pharmaceuticals: MajorHealth Technology Develops glucocorticoids for the patients suffering from acute allergic conditions | Health Technology |
Chalmers Ventures AB
Chalmers Ventures AB Investment ManagersFinance Chalmers Ventures invests in companies located in Sweden. The firm targets companies operating in the field of technology sector. It provides financing for pre-seed, seed & growth stage capital requirements with an investment size of up to SEK 1 million in pre-seed stage, up to SEK 5 million in seed stage and up to SEK 20 million in growth stage transactions. It also act as co-investor. | Finance |
Mevia AB
Mevia AB Other Consumer ServicesConsumer Services Provides drug package that helps patients manage their drug intake | Consumer Services |
Stayble Therapeutics AB
 Stayble Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops drugs to treat disco genic chronic low back pain | Health Technology |
Ziccum AB
 Ziccum AB Medical SpecialtiesHealth Technology Develops new dry powder preparations of biological pharmaceuticals | Health Technology |
Magamu AB
Magamu AB Miscellaneous Commercial ServicesCommercial Services Engages in trading of goods | Commercial Services |
Alpha Theraphy Solutions AB | |
Atley Solutions AB
Atley Solutions AB Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
